In addition, saturation of receptors and continued use of the peptide may cause the onset of abdominal and bone growth
Semaglutide, a glucagon-like peptide receptor agonist (GLP-1 RA), is the active ingredient in Ozempic and Wegovy, two medications being prescribed with increasing frequency across the US, adding to a cause for concern about the study's findings
Some research in animal models suggests that it supports lean muscle growth and reduces fatigue
By contrast, BPs may allow residual protection against fracture even after treatment cessation
In addition to a positive effect on body mass, Ozempic also positively influences ones cardiovascular health and reduces the chances of heart attacks and strokes
Plan ahead by reviewing menus and choosing semaglutide-friendly options